GlaxoSmithKline secured FDA approval for Nucala, an injectable treatment for asthma, a therapeutic dominated by inhaled drugs. Still, the alternative form of…

Amgen's Imlygic became the first genetically modified oncolytic viral therapy to earn FDA approval.

The only inhaler that administers a slow-moving mist to help respiratory patients inhale the medication is now FDA-approved for the long-term maintenance…

Titan Pharmaceuticals announced that it has resubmitted its application for FDA approval of its subdermal implant for the delivery of buprenorphine/naloxone as…

California's NanoSmart netted an orphan designation to treat the rare Ewing's sarcoma, a childhood bone cancer, with a product that makes use…

The FDA on Monday approved Aprecia Pharmaceuticals' Spritam, which is the first 3-D-printed product designed for use in the human body. The drug is…

Pfizer just announced that the FDA agreed to review a daily, 11-milligram modified-release tablet of its rheumatoid arthritis drug Xeljanz for patients who don…

The FDA warned that a transdermal patch to treat ADHD in children and adolescents can lead to chemical leukoderma, or permanent skin discoloration, as a result…

Regulatory